PNC-27 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
PNC-27 is being researched for skin applications. Binds to HDM-2 on cancer cell plasma membranes (residues 1-109), inducing transmembrane pore formation and necrosis. Additionally penetrates cancer cells and disrupts mitochondrial membranes, causing . Common dosages for this use range from >10 mcg/mL (in vitro effective concentration); clinical dosing not established not established for human use.
Can PNC-27 Help With Skin?
PNC-27 (PNC-27 (p53-penetratin chimeric peptide)) is being researched for skin applications based on its mechanism as a Cell-penetrating therapeutic peptide.
Binds to HDM-2 on cancer cell plasma membranes (residues 1-109), inducing transmembrane pore formation and necrosis. Additionally penetrates cancer cells and disrupts mitochondrial membranes, causing apoptosis. Kills cancer cells regardless of their p53 mutation status.
What Does the Research Show for PNC-27 and Skin?
Demonstrated efficacy against breast, pancreatic, lung, colon, ovarian, and leukemia cancer cells ex vivo. Research spans 2008-2024 with consistent findings of cancer cell selectivity. Clinical trials conducted outside USA reportedly successful. No US clinical trials.
The relevance to skin specifically comes from PNC-27's effects on broad-spectrum cancer cell killing, p53-independent mechanism, minimal normal cell toxicity, rapid killing kinetics (90 minutes).
What Protocol Is Used for Skin?
For skin applications, the standard PNC-27 protocol is >10 mcg/mL (in vitro effective concentration); clinical dosing not established administered not established for human use via local application (proposed: nebulizer, suppository, IV at tumor site) for unknown; 90-minute killing kinetics in vitro.
Some researchers adjust dosing based on the specific skin application — see our PNC-27 dosage guide for full protocol details.
Can Stacking Improve Skin Results?
Unique mechanism (HDM-2 binding) differs from all conventional cancer drugs, enabling potential combination therapy.
What Side Effects Apply to Skin Use?
Limited safety data. No apparent toxicity to normal tissue in culture. Potential immune responses to foreign peptide.
Side effects are generally consistent regardless of the specific application. See our PNC-27 side effects guide for details.
Calculate Your PNC-27 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for PNC-27.
Open Calculator →Bottom Line: PNC-27 for Skin
PNC-27 shows preliminary research potential for skin. Standard protocols (>10 mcg/mL (in vitro effective concentration); clinical dosing not established, not established for human use, unknown; 90-minute killing kinetics in vitro) apply.
Source from COA-tested vendors and maintain consistent dosing for the full cycle duration.
Complete Guide
PNC-27 : Benefits, Dosage, Side Effects & Research
Related Reading
- PNC-27 Dosage Guide
- PNC-27 Benefits
- PNC-27 Side Effects
- PNC-27 Stacking Guide
- PNC-27 Cycle Guide
- PNC-27 Research
Research-Grade Sourcing
If you're going to research PNC-27, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is PNC-27?
PNC-27 (PNC-27 (p53-penetratin chimeric peptide)) is a Cell-penetrating therapeutic peptide. 32-residue chimeric peptide combining an HDM-2 binding domain from p53 with a cell-penetrating penetratin sequence. It is researched for broad-spectrum cancer cell killing, p53-independent mechanism, minimal normal cell toxicity, rapid killing kinetics (90 minutes).
What is the recommended PNC-27 dosage?
Common dosages: >10 mcg/mL (in vitro effective concentration); clinical dosing not established administered not established for human use via local application (proposed: nebulizer, suppository, IV at tumor site). Cycle length: unknown; 90-minute killing kinetics in vitro. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of PNC-27?
Limited safety data. No apparent toxicity to normal tissue in culture. Potential immune responses to foreign peptide.
Is PNC-27 safe?
PNC-27 has shown a preliminary safety profile in research. Not FDA-approved in USA. Clinical trials conducted internationally. Research use only in US. All research should follow appropriate safety protocols.